DCAL

Dishman Carbogen Amcis Share Price

 

 

Start SIP in DCAL

Start SIP

Performance

  • Low
  • ₹253
  • High
  • ₹261
  • 52 Week Low
  • ₹178
  • 52 Week High
  • ₹322
  • Open Price₹254
  • Previous Close₹256
  • Volume104,231

Investment Returns

  • Over 1 Month + 7.08%
  • Over 3 Month -17%
  • Over 6 Month + 5.7%
  • Over 1 Year -4.88%

Smart Investing Starts Here Start SIP with Dishman Carbogen Amcis for Steady Growth!

Invest Now

Dishman Carbogen Amcis Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 29.3
  • PEG Ratio
  • 0.2
  • Market Cap Cr
  • 3,995
  • P/B Ratio
  • Average True Range
  • 12.38
  • EPS
  • 9.53
  • Dividend Yield
  • 0
  • MACD Signal
  • -4.47
  • RSI
  • 56.57
  • MFI
  • 73.39

Dishman Carbogen Amcis Financials

Dishman Carbogen Amcis Technicals

EMA & SMA

Current Price
₹254.80
-0.88 (-0.34%)
pointer
  • Bearish Moving Average 4
  • Bullish Moving Average 12
  • 20 Day
  • ₹242.23
  • 50 Day
  • ₹250.14
  • 100 Day
  • ₹255.07
  • 200 Day
  • ₹249.87

Resistance and Support

256.3 Pivot Speed
  • R3 267.40
  • R2 264.20
  • R1 259.50
  • S1 251.60
  • S2 248.40
  • S3 243.70

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Dishman Carbogen Amcis Ltd. is a leading global contract research and manufacturing organization (CRMO) based in India, specializing in pharmaceutical and biotechnology services. The company focuses on providing high-quality, innovative solutions in API production and custom synthesis.

Dishman Carbogen Amcis has an operating revenue of Rs. 2,759.38 Cr. on a trailing 12-month basis. An annual revenue growth of 3% is not great, Pre-tax margin of 1% needs improvement, ROE of 0% is poor and needs improvement. The company has a reasonable debt to equity of 20%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its key moving averages, around -0% and 2% from 50DMA and 200DMA. It needs to stay above these levels to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 20% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 67 which is a FAIR score but needs to improve its earnings, a RS Rating of 57 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 71 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Dishman Carbogen Amcis Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-12-27 Others
2025-11-04 Quarterly Results
2025-08-12 Quarterly Results & Fund raising
2025-05-21 Audited Results
2025-03-12 To consider Fund Raising Inter alia, to consider 1. Proposal of fund raising by way of issuance of Non-Convertible Debentures, by way of private placement, subject to such regulatory or statutory approvals as may be required.

Dishman Carbogen Amcis F&O

Dishman Carbogen Amcis Shareholding Pattern

59.32%
1.08%
0%
8.07%
0%
26.84%
4.69%

About Dishman Carbogen Amcis

  • NSE Symbol
  • DCAL
  • BSE Symbol
  • 540701
  • Managing Director
  • Mr. Arpit J Vyas
  • ISIN
  • INE385W01011

Similar Stocks to Dishman Carbogen Amcis

Dishman Carbogen Amcis FAQs

Dishman Carbogen Amcis share price is ₹254 As on 25 December, 2025 | 03:41

The Market Cap of Dishman Carbogen Amcis is ₹3994.8 Cr As on 25 December, 2025 | 03:41

The P/E ratio of Dishman Carbogen Amcis is 29.3 As on 25 December, 2025 | 03:41

The PB ratio of Dishman Carbogen Amcis is 0.6 As on 25 December, 2025 | 03:41

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23